Background: Stroke unit care is associated with decrease in mortality and improvement in neurological outcome in patients with acute stroke. Heart rate is a commonly monitored variable in the stroke unit. However, little is known about tachycardia burden in the stroke unit and its association with outcome.
Introduction
Stroke unit (SU) care has been shown to render significant benefit to patient with acute stroke by decreasing mortality and morbidity. [1] [2] [3] [4] [5] Early detection and timely management of neurological and medical complications may account for beneficial effects of SU care. [6] [7] [8] In addition to blood pressure, electrocardiogram (ECG), respiration or oxygen saturation, and heart rate are commonly monitored physiologic variables in the SU. [9] [10] [11] However, clinical utility of continuous heart rate monitoring still remains to be elucidated in the setting of acute ischemic stroke. Tachycardia can be triggered by various clinical scenarios including enhanced catecholamine release, fever, volume depletion, sepsis, anemia, hypoxia or anxiety. 12 Increased tachycardia burden is associated with major cardiac event in critically ill, cardiac high risk patients. 13 Moreover, prolonged elevated heart rate is significantly associated with poor functional outcome and major Department of Neurology, Seoul National University Hospital, Seoul, Republic of Korea The first two authors contributed equally to this article. cardiopulmonary events in patients with subarachnoid hemorrhage (SAH). 14 However, it is not clear whether tachycardia is associated with functional outcome in patients with acute ischemic stroke. In this study, we sought to investigate the association of tachycardia burden during SU stay and three-month functional outcome after ischemic stroke.
Methods

Collection of patients' data
A total of 356 consecutive patients with acute ischemic stroke and transient ischemic attack (TIA) ( 7 days after onset) were admitted to SU between July 2013 and June 2014. Patients with enough data for analysis (SU monitoring time >12 h) were included. Therefore, a third of patients (n ¼ 105) were excluded. We also excluded five patients who had no information of modified Rankin Scale (mRS) score at three months after stroke due to loss of follow-up. Finally, a total of 246 patients were included for analysis. The analysis was performed retrospectively using a prospectively collected stroke registry database. This study was approved by the Institutional Review Board at the Seoul National University Hospital (IRB approval No. H-1212-087-450).
Definition of clinical information
We collected baseline demographic, clinical, and laboratory information for all study participants, including age, sex, initial systolic and diastolic blood pressure, history of previous stroke, and cardiovascular risk factors. [15] [16] [17] Stroke characteristics included National Institutes of Health Stroke Scale (NIHSS) score at admission, thrombolytic treatment, pneumonia in the first two weeks of admission, and mRS score at three months after stroke. TIA was defined as stroke symptoms lasting less than<24 h. Stroke subtype was categorized using Trial of ORG 10172 in Acute Stroke Treatment classification. 18 
Monitoring data acquisition
A high resolution data acquisition system (BedmasterEX, Excel Medical Electronics) was used to acquire digital data including blood pressure, heart rate and body temperature in the SU via GE Dash 4000 monitor. Physiologic variables were sampled every 1 min. Heart rate of >95 beats per minute was defined as an occurrence of tachycardia based on previous study. 13, 14 Tachycardia burden was defined as duration of heart rate over 95/min divided by the total monitoring time. Fever was defined as body temperature elevation over 37.5 C. 19, 20 
Statistical analyses
Poor functional outcome was defined as three-month mRS score of 3-6. Differences between continuous variables were analyzed using the t test and differences between categorical variables were analyzed using the 2 test or Fisher exact test, as appropriate. Logistic regression analysis was used to evaluate the association between tachycardia burden and functional outcome at three months. Significance levels were set at a p value of <0.05. Statistical analyses were performed using R statistical software (R, version 3.1.1, R Project).
Results
A total of 246 consecutively admitted patients were included. Excluded patients (n ¼ 110) were more likely to be male (66.4% vs. 53.7%, p ¼ 0.03) with less hypertension (57.3% vs. 72.8%, p < 0.01) compared to the study subjects. All other baseline characteristics were not different between the two groups ( Table 1 ).
Mean age of study patients was 67.4 (standard deviation; 12.8) with higher proportion of male (53.7%). The risk factors included hypertension in 179 (72.8%) patients, diabetes mellitus in 74 (30.1%) patients, hyperlipidemia in 78 (31.7%) patients, habitual smoking in 72 (29.3%) patients, and atrial fibrillation (AF) in 57 (23.2%) of patients. Twenty-five patients (10.2%) had transient ischemia attack. The median NIHSS score at admission was 3 (interquartile range, 1-7) and 8.5% (n ¼ 21) of patients received thrombolytic treatment. Sixty-seven (27.2%) patients had fever in the SU and 30 (12.2%) patients had pneumonia in the first two weeks of admission.
Association between tachycardia and functional outcome
Tachycardia burden, the duration of heart rate over 95/ min divided by the total monitoring time, was classified into quartiles (median, 0.7%; interquartile range, 0.1-5.7%) ( Table 2 , Supplementary Table 1 ). The patients with the highest tachycardia burden (!6.0%) were older, more likely to have diabetes, AF, cardioembolic etiology with higher stroke severity at admission, stayed longer in the SU. In addition, they were more likely to have fever in the SU, pneumonia in the first two weeks of admission, and poor functional outcome (mRS 3-6). They were more likely to have higher white blood cell count, initial fasting glucose, HbA1c, but lower hematocrit.
As expected, the patients with the poor functional outcome were older (74.5 years vs. 63.7 years, p < 0.01), had higher initial stroke severity (median NIHSS 7 vs. 2, p < 0.01), higher initial fasting glucose (112 mg/dL vs. 101 mg/dL, p ¼ 0.02), higher proportion of fever Increased tachycardia burden was associated with an increased odd for poor outcome (mRS 3-6) (odds ratio 1.36, 3.60, and 13.42 in 2nd, 3rd, and 4th quartiles; p for trend, <0.01). As compared with the lowest quartile (<0.1%), the fourth quartile of tachycardia burden (!6.0%) was significantly associated with the poor outcome (adjusted odds ratio, 5.10; 95% confidence interval, 1.38-18.90; p ¼ 0.01) after adjusting for confounding variables with bivariate p values <0.05 (age, transient ischemia attack, stroke subtype, initial stroke severity, AF, thrombolytic treatment, fever, pneumonia, initial fasting glucose, hematocrit and total monitoring time) (Table 3; Figure 1 ).
Discussion
In this study, we found that increased tachycardia burden during SU stay was associated with overall mortality and disability in patients with acute ischemic stroke. About 68% of the patients in the highest quartile of tachycardia burden (!6.0%) had poor functional outcome. The association between tachycardia and functional outcome in patients with acute stroke is controversial. One study showed elevated heart rate in subacute phase after stroke is a risk indicator for mortality and poor functional outcome. 21 However, it was unknown whether tachycardia is important in stroke patients with acute phase when heart related change is more important in prognosis. 22, 23 A recent study on acute stroke patients showed tachycardia is frequent phenomenon, while its association to poor functional outcome is not significant. 23 However, the study evaluated merely the occurrence of tachycardia within 24 h as 'yes or no', thus could not assess overall burden of tachycardia during SU stay. However, our study analyzed heart rate data with 1-min resolution. Therefore, we could evaluate tachycardia burden as the percentage of duration of tachycardia per total monitoring time from continuous ECG monitoring using high resolution data acquisition system. With these strength, we think that our study provides more accurate information on the relationship between tachycardia and clinical outcome.
The factors associated with poor outcome in patients with stroke were old age, initial stroke severity, stroke progression, recurrence, and medical complications such as pneumonia. 7, [24] [25] [26] Likewise, the patients with higher tachycardia burden also were more likely to be old, had higher initial NIHSS score and higher incidence of fever and pneumonia. However, tachycardia burden still showed significant association with poor functional outcome after adjusting for covariates described above.
Well-known causes of tachycardia such as sympathetic hyperactivity, pain, agitation, volume depletion, anemia, heart failure, and chronic pulmonary disease are frequent in the acute stroke population. 12 Unfortunately, identifying the main cause of tachycardia which drives the association with poor outcomes is not possible in our study. In addition, it is not clear whether tachycardia itself has a direct negative effect on functional outcome or tachycardia just reflects poor clinical conditions. It is likely that multiple factors may be contributing to this association of tachycardia and poor outcomes. Our finding that tachycardia was strongly associated with poor functional outcome after controlling for potential factors associated poor outcomes suggests that tachycardia is at least a surrogate marker for multiple neurologic and/or medical worsening. One possibility is that pathologic sympathetic activation during the acute phase of stroke may be a predictor of future cardiovascular and cerebrovascular events. 27 Several studies have shown that elevated heart rate is associated with plaque rupture 28 and recurrent myocardial infarction with coronary artery disease. 29 There are several limitations in our study. First, our study is a retrospective study which excluded a significant numbers of patients due to lack of data for analysis, therefore, there is a chance for selection bias. However, excluded patients were not different except for sex and hypertension compared to study population, suggesting that the chances of selection bias are not high. Second, the association of tachycardia and early neurologic deterioration could not be assessed in our study. The lack of information on the specific time point of neurologic worsening and tachycardia occurrence limits the interpretation and further studies are needed to investigate timing of tachycardia and neurologic symptoms. Third, we tried to adjust pneumonia and fever as a possible confounder of fever in analyzing data, however, many unmeasured possible causes of tachycardia may still exist. Volume depletion may be one of the triggering factors of tachycardia in unstable patients. However, our patients were treated aggressively with hydration with normal saline. Therefore, the chances of hypovolemia in our patients are not high. Fourth, there is still a chance that more severe cardioembolic stroke patient had higher tachycardia burden due to frequent AF rapid ventricular response (RVR). In order to solve this issue, we adjusted AF in analyzing the association between tachycardia and functional outcome, and the correlation was still valid even after adjusting covariates.
Conclusions
In conclusion, an increased tachycardia burden during SU stay is associated with poor three-month functional outcome, which underscores importance of continuous heart rate monitoring in the SU. Moreover, it could be inferred from our results that countermeasures against worsening factors might be utilized for patients with increased tachycardia burden. Future clinical studies are needed analyzing occurrence of early neurologic deterioration and its association with increased tachycardia burden. 
